ACA Stock Analysis: Buy, Sell, or Hold?
ACA - Arcosa, Inc. Common Stock
$144.92
-0.08 (-0.06%)
▼
5d:
-0.32%
30d:
+17.96%
90d:
+29.86%
HOLD
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 06, 2026
22d
Get Alerted When ACA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ACA trades at premium valuation expecting 6.7% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: ACA trades at premium valuation expecting 6.7% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$191.72
Based on 10.0% avg growth
INTRINSIC VALUE TODAY
$119.04
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 23.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ACA is currently trading at $144.92, which is considered slightly high relative to its 30-day fair value range of $128.84 to $146.57. From a valuation perspective, the stock is trading at a premium (Forward PE: 28.5) compared to its historical average (23.5). At these levels, the market is pricing in 6.7% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, ACA is in a strong uptrend. The price is currently testing key support at $144.21. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ACA is in a strong uptrend. The price is currently testing key support at $144.21. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$128.84 -
$146.57
Company Quality Score
59/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
54.8%
All Signals
- NEUTRAL: Mixed technical signals (40/100)
- NEUTRAL: Near Wall St target ($145.50)
- NEUTRAL: Trading at premium valuation - market expects 6.7% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$128.84 -
$146.57
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$144.21
Resistance Level
$146.00
Current Trend
Strong Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
28.50
Wall Street Target
$145.50
(+0.4%)
Revenue Growth (YoY)
4.4%
Earnings Growth (YoY)
57.8%
Profit Margin
7.7%
Valuation Premium vs History
+6.7% premium
PE vs Historical
28.5 vs 23.5
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.7%
(market-implied from PE analysis)
1-Year Target
$154.63
(+7%)
2-Year Target
$164.99
(+14%)
3-Year Target
$176.04
(+22%)
3-Yr Target (if PE normalizes)
(PE: 29→24)
PE COMPRESSION
$145.15
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 28.5, Growth: 16.0%)
$226.11
(+56%)
Base:
(SPY PE: 21.8, Growth: 16.0%)
$172.78
(+19%)
Bear:
(PE: 18.5, Growth: 16.0%)
$146.86
(+1%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (32x PE), but valuation improves significantly next year (29x PE) as earnings recover.
Trailing PE: 32.44 | Current EPS (TTM): $4.47
Bull Case
$181.43
(+25%)
Analyst growth 13.7%, PE expands to 35.7
Base Case
$164.93
(+14%)
Market implied 13.7%, PE stable at 32.4
Bear Case
$98.60
(-32%)
Severe decline -20.0%, PE contracts to 27.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 13, 2026 8:07 PM ET
Data refreshes hourly during market hours. Next update: 9:07 PM
Data refreshes hourly during market hours. Next update: 9:07 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ACA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Featured in Portfolios
ACA is a key holding in these high-performance investment strategies.
Top Rated Engineering & Construction Stocks
Top-rated stocks in Engineering & Construction by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
PWR
Quanta Services Inc |
STRONG BUY
30 analysts |
$761 | 59 HOLD |
|
MTZ
MasTec Inc |
STRONG BUY
17 analysts |
$480 | 53 HOLD |
|
J
Jacobs Solutions Inc. |
BUY
17 analysts |
$157 | 60 HOLD |
|
ACM
Aecom Technology Corpora… |
STRONG BUY
13 analysts |
$101 | 57 HOLD |
|
STN
Stantec Inc |
STRONG BUY
11 analysts |
$94 | 58 HOLD |
